SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-051339
Filing Date
2017-09-05
Accepted
2017-09-05 16:38:44
Documents
1
Period of Report
2017-08-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3377
  Complete submission text file 0001209191-17-051339.txt   4767
Mailing Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 370 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Issuer) CIK: 0001403708 (see all company filings)

IRS No.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O EVOKE PHARMA, INC. 505 LOMAS SANTA FE DRIVE SOLANA BEACH CA 92075
Business Address
Gonyer David A (Reporting) CIK: 0001578768 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36075 | Film No.: 171069171